Titan Pharmaceuticals
TTNP
#10579
Rank
A$8.72 M
Marketcap
A$6.56
Share price
-3.76%
Change (1 day)
7.83%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -A$4.33 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$6.7 Million, an increase over its 2023 earnings that were of -A$7.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.33 Million-35.43%
2024 -A$6.7 Million-15.5%
2023 -A$7.93 Million-45.43%
2022 -A$14.52 Million16.29%
2021 -A$12.49 Million-907.36%
2020 A$1.54 M-106.6%
2019 -A$23.42 Million82.4%
2018 -A$12.84 Million-36.93%
2017 -A$20.36 Million-378.62%
2016 A$7.3 M-145.53%
2015 -A$16.05 Million369.37%
2014 -A$3.42 Million-125.9%
2013 A$13.19 M-177.74%
2012 -A$16.98 Million13.59%
2011 -A$14.95 Million74.37%
2010 -A$8.58 Million3.61%
2009 -A$8.28 Million
2007 -A$26.23 Million12.08%
2006 -A$23.4 Million-28.65%
2005 -A$32.8 Million-10.03%
2004 -A$36.45 Million-6.08%
2003 -A$38.81 Million-14.76%
2002 -A$45.53 Million32.52%
2001 -A$34.36 Million27.55%
2000 -A$26.94 Million62.5%
1999 -A$16.58 Million4.04%
1998 -A$15.94 Million49.33%
1997 -A$10.67 Million-27.88%
1996 -A$14.8 Million13.04%
1995 -A$13.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.95 B-926,267.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.45 B-562,809.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-A$0.18 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$0.11 B-3,090.94%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$17.08 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.41 Billion 10,144.78%๐Ÿ‡บ๐Ÿ‡ธ USA